Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Current Assets: 2017-2023

Historic Current Assets for Solid Biosciences (SLDB) over the last 7 years, with Dec 2023 value amounting to $129.7 million.

  • Solid Biosciences' Current Assets rose 21.00% to $179.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $179.5 million, marking a year-over-year increase of 21.00%. This contributed to the annual value of $129.7 million for FY2023, which is 40.93% down from last year.
  • Solid Biosciences' Current Assets amounted to $129.7 million in FY2023, which was down 40.93% from $219.6 million recorded in FY2022.
  • Over the past 5 years, Solid Biosciences' Current Assets peaked at $222.6 million during FY2021, and registered a low of $86.3 million during FY2019.
  • Over the past 3 years, Solid Biosciences' median Current Assets value was $219.6 million (recorded in 2022), while the average stood at $190.7 million.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 84.12% in 2020, then crashed by 40.93% in 2023.
  • Over the past 5 years, Solid Biosciences' Current Assets (Yearly) stood at $86.3 million in 2019, then skyrocketed by 84.12% to $158.9 million in 2020, then skyrocketed by 40.09% to $222.6 million in 2021, then decreased by 1.34% to $219.6 million in 2022, then slumped by 40.93% to $129.7 million in 2023.